226 related articles for article (PubMed ID: 18219287)
21. Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
Loibl S; von Minckwitz G; Raab G; Blohmer JU; Dan Costa S; Gerber B; Eidtmann H; Petrich S; Hilfrich J; Jackisch C; du Bois A; Kaufmann M
Ann Surg Oncol; 2006 Nov; 13(11):1434-42. PubMed ID: 16983592
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study.
Volders JH; Haloua MH; Krekel NM; Negenborn VL; Barbé E; Sietses C; Jóźwiak K; Meijer S; van den Tol MP;
Eur J Surg Oncol; 2016 Jul; 42(7):986-93. PubMed ID: 27211343
[TBL] [Abstract][Full Text] [Related]
23. Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients.
Michishita S; Kim SJ; Shimazu K; Sota Y; Naoi Y; Maruyama N; Kagara N; Shimoda M; Shimomura A; Noguchi S
Breast; 2015 Apr; 24(2):159-65. PubMed ID: 25805427
[TBL] [Abstract][Full Text] [Related]
24. Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer.
Aguiar Bujanda D; Bohn Sarmiento U; Cabrera Suárez MA; Pavcovich Ruiz M; Limeres González MA; Aguiar Morales J
J Cancer Res Clin Oncol; 2006 May; 132(5):332-8. PubMed ID: 16435143
[TBL] [Abstract][Full Text] [Related]
25. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?
Heil J; Schaefgen B; Sinn P; Richter H; Harcos A; Gomez C; Stieber A; Hennigs A; Rauch G; Schuetz F; Sohn C; Schneeweiss A; Golatta M
Eur J Cancer; 2016 Dec; 69():142-150. PubMed ID: 27821317
[TBL] [Abstract][Full Text] [Related]
26. Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer.
Walker LG; Eremin JM; Aloysius MM; Vassanasiri W; Walker MB; El-Sheemy M; Cowley G; Beer J; Samphao S; Wiseman J; Jibril JA; Valerio D; Clarke DJ; Kamal M; Thorpe GW; Baria K; Eremin O
BMC Cancer; 2011 May; 11():179. PubMed ID: 21592370
[TBL] [Abstract][Full Text] [Related]
27. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
28. MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes.
Nakahara H; Yasuda Y; Machida E; Maeda Y; Furusawa H; Komaki K; Funagayama M; Nakahara M; Tamura S; Akiyama F
Breast Cancer; 2011 Jul; 18(3):152-60. PubMed ID: 21086082
[TBL] [Abstract][Full Text] [Related]
29. Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.
Ma Y; Zhang S; Zang L; Li J; Li J; Kang Y; Ren W
Eur J Cancer; 2016 Dec; 69():86-101. PubMed ID: 27821323
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer.
Charehbili A; Wasser MN; Smit VT; Putter H; van Leeuwen-Stok AE; Meershoek-Klein Kranenbarg WM; Liefers GJ; van de Velde CJ; Nortier JW; Kroep JR
Eur J Surg Oncol; 2014 Oct; 40(10):1216-21. PubMed ID: 25150151
[TBL] [Abstract][Full Text] [Related]
31. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
32. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Kim YI; Yoon HJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kim EE; Moon WK; Kang KW
Clin Nucl Med; 2016 Aug; 41(8):614-20. PubMed ID: 27276207
[TBL] [Abstract][Full Text] [Related]
34. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
Fujisawa T; Hirakata T; Yanagita Y; Iijima M; Horikoshi H; Takeuchi K; Saitoh Y
Breast Cancer; 2013 Jan; 20(1):75-82. PubMed ID: 22203579
[TBL] [Abstract][Full Text] [Related]
35. The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.
Straver ME; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Wesseling J; Russell NS; Oldenburg HS; Antonini N; Vrancken Peeters MT
Ann Surg Oncol; 2010 Sep; 17(9):2411-8. PubMed ID: 20373039
[TBL] [Abstract][Full Text] [Related]
36. MRI-based 3D-printed surgical guides for breast cancer patients who received neoadjuvant chemotherapy.
Ko BS; Kim N; Lee JW; Kim HJ; Chung IY; Kim J; Lee SB; Son BH; Kim HH; Seo JB; Kim SB; Gong GY; Kim GB; Lee S; Choi SH; Ahn SH
Sci Rep; 2019 Aug; 9(1):11991. PubMed ID: 31427647
[TBL] [Abstract][Full Text] [Related]
37. Completion mastectomy after breast conserving surgery.
O'Donnell ME; Salem A; Badger SA; Sharif MA; Lioe T; Spence RA
Breast; 2008 Apr; 17(2):199-204. PubMed ID: 18024117
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
39. Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy.
Davoine E; Dion L; Nyangoh Timoh K; Beraud E; Tas P; Tavenard A; Laviolle B; Perrin C; Foucher F; Levêque J; Lavoué V
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):467-472. PubMed ID: 31207391
[TBL] [Abstract][Full Text] [Related]
40. Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.
Barrou J; Bannier M; Cohen M; Lambaudie E; Gonçalves A; Bertrand P; Buttarelli M; Opinel P; Sterkers N; Tallet A; Zinzindohoué C; Houvenaeghel G
Breast; 2017 Apr; 32():37-43. PubMed ID: 28033508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
